ArticleCurrent stem cell research & therapy2025
Regenerative Therapy for Deep Burn Injury using Mesenchymal Stem Cells and Myrtle (Myrtus Communis) in a Rat Model.
Article in Current stem cell research & therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Anti-inflammatory effects of Myrtus communis L. (myrtle): experimental and clinical evidence with an immunological perspective.Inflammopharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBurn injuries pose a significant health challenge, leading to intense physiological stress compared to other types of trauma. Myrtle has been traditionally used for treating various skin ailments, while mesenchymal stem cells (MSCs) have introduced innovative approaches for burn treatment. This study aimed to evaluate the impact of myrtle compared to MSCs on the healing of deep second-degree burns.
methodsFifty adult male albino rats were randomly divided into five groups: Group A served as the control, Group B received an excision burn without treatment, Group C was treated with topical myrtle paste, Group D received an intradermal injection of mesenchymal stem cells (MSCs), and Group E received both topical myrtle paste and intradermal MSC injection. Burn healing was assessed based on visible characteristics over 21 days. At the end of the treatment, skin samples were collected for biochemical analysis, histological examination using hematoxylin and eosin (H&E) staining, and VEGF concentration measurement via ELISA. Additionally, PCR analysis was conducted to assess the expression levels of COL1a1, COL3a1, TNF-α, and IL-6, providing insights into collagen production and inflammatory response.
resultsGross evaluation and histopathological analysis indicated that Groups D and E exhibited complete skin regeneration compared to the burn group. VEGF analysis demonstrated enhanced angiogenesis in the treated groups. PCR analysis revealed upregulation of COL1a1 and COL3a1, along with downregulation of TNF-α and IL-6, suggesting reduced inflammation and improved skin healing.
conclusionThe study demonstrated that both MSCs and myrtle contributed to significant burn healing. The combination of myrtle and MSCs (Group E) exhibited the most effective skin regeneration, likely due to enhanced collagen production, reduced inflammation, and improved angiogenesis. These findings suggest that combining traditional herbal treatments with stem cell therapy may offer a promising strategy for burn management.
Indexed as
Identifiers
40468927What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.